Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Abbas G. Hamedani"'
Publikováno v:
Journal of drugs in dermatology : JDD. 13(10)
Severe chronic hand eczema (sCHE) is a persistent, disfiguring disease that responds poorly to conventional treatment and causes substantial physical and psychological disability. The objective of this study was to evaluate efficacy and safety of ora
Autor:
Stuart M. Harding, Nancy Herje, James T.C. Li, Tushar Shah, Paul Chervinsky, Abbas G. Hamedani, Donald J Kellerman, Kenneth G. Faulkner, Stephen C. Weisberg, Linda B. Ford
Publikováno v:
Journal of Allergy and Clinical Immunology. 103:1062-1068
Background: Although inhaled corticosteroids are widely used for the treatment of inflammation in asthma, prospective, long-term, placebo-controlled trials characterizing their systemic safety with chronic use are lacking. Objective: This study was d
Autor:
Tushar Shah, Jill P. Wolford, Bennett P. deBoisblanc, Abbas G. Hamedani, William Busse, H. Nelson, Michael Noonan, Puneet Mahajan, Stuart M. Harding, D.Robert Webb, William E. Berger
Publikováno v:
Journal of Allergy and Clinical Immunology. 103:267-275
Background: Many patients with severe asthma are dependent on oral corticosteroids for maintenance control of their disease. Treatments that allow patients to be weaned off oral corticosteroids may help to minimize the risk of side effects associated
Autor:
Michael Noonan, David B. Peden, M.Ross Thomas, Karen W. House, Puneet Mahajan, William E. Berger, Abbas G. Hamedani, Virginia L. Hendricks
Publikováno v:
The Journal of allergy and clinical immunology. 102(1)
Inhaled corticosteroids are increasingly being used to treat mild-to-moderate asthma in children. However, data regarding therapy with this class of compounds, especially in children under age 6 years, is limited. Fluticasone propionate is a third ge
Autor:
Michael Noonan, Abbas G. Hamedani, David S. Pearlman, Amy Schaberg, Marc F. Goldstein, Donald J Kellerman, Donald P. Tashkin
Publikováno v:
Annals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology. 78(4)
Fluticasone propionate, an inhaled corticosteroid with negligible systemic bioavailability via the oral route, is efficacious in the treatment of asthma when administered via metered-dose inhaler.To evaluate the efficacy and safety of inhaled flutica
Autor:
David J. McSorley, Eric G. Carter, Abbas G. Hamedani, Northcutt Allison Ruth, Vanessa Z. Ameen, Teresa L. Perschy
Publikováno v:
American Journal of Gastroenterology. 99:S275